tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Crescent Biopharma initiated with an Outperform at LifeSci Capital

LifeSci Capital analyst Charles Zhu initiated coverage of Crescent Biopharma (CBIO) with an Outperform rating and $22 price target

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1